United States· US:69945-177_5b8746b6-9986-11cc-e063-6394a90af38b
BEXLUTRY
A medicinal product containing lutetium oxodotreotide lu-177, registered in United States by Curium US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LUTETIUM OXODOTREOTIDE LU-177
- Manufacturer
- Curium US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1169945-177-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium oxodotreotide lu-177 in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLUTATHERANOVARTIS PHARMACEUTICALS CANADA INC
- CzechiaLUTATHERANovartis Europharm Limited, Dublin
- FinlandLutatheraNovartis Europharm Limited
- NetherlandsLutathera 370 MBq/ml, oplossing voor infusieNovartis Europharm Limited
- NorwayLutatheraNovartis Europharm Limited
- SwedenLutathera 370 MBq/ml Infusionsvätska, lösningNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lutathera
- Liechtenstein · Lutathera
- Norway · Lutathera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1d910fa-238e-4297-9dfa-1f932cdcf9fb GET /v1/drugs/c1d910fa-238e-4297-9dfa-1f932cdcf9fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "10",
"substance": "LUTETIUM OXODOTREOTIDE LU-177",
"productndc": "69945-177",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA218525",
"marketing_category": "NDA"
}See everything about lutetium oxodotreotide lu-177.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.